Global Viral Vector and Plasmid DNA Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Viral Vector and Plasmid DNA market size is predicted to grow from US$ 927 million in 2025 to US$ 2771 million in 2031; it is expected to grow at a CAGR of 20.0% from 2025 to 2031.
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
Global Viral Vector and Plasmid DNA key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections, etc.
LPI (LP Information)' newest research report, the “Viral Vector and Plasmid DNA Industry Forecast” looks at past sales and reviews total world Viral Vector and Plasmid DNA sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Vector and Plasmid DNA sales for 2025 through 2031. With Viral Vector and Plasmid DNA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector and Plasmid DNA industry.
This Insight Report provides a comprehensive analysis of the global Viral Vector and Plasmid DNA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector and Plasmid DNA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector and Plasmid DNA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector and Plasmid DNA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector and Plasmid DNA.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector and Plasmid DNA market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Viral Vector and Plasmid DNA market size is predicted to grow from US$ 927 million in 2025 to US$ 2771 million in 2031; it is expected to grow at a CAGR of 20.0% from 2025 to 2031.
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
Global Viral Vector and Plasmid DNA key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections, etc.
LPI (LP Information)' newest research report, the “Viral Vector and Plasmid DNA Industry Forecast” looks at past sales and reviews total world Viral Vector and Plasmid DNA sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Vector and Plasmid DNA sales for 2025 through 2031. With Viral Vector and Plasmid DNA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector and Plasmid DNA industry.
This Insight Report provides a comprehensive analysis of the global Viral Vector and Plasmid DNA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector and Plasmid DNA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector and Plasmid DNA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector and Plasmid DNA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector and Plasmid DNA.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector and Plasmid DNA market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Plasmid DNA
- Viral Vector
- Cancer
- Virus Infection
- Hereditary Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Brammer Bio
- Oxford BioMedica
- Cobra Biologics
- FinVector
- Lonza
- BioReliance
- MolMed
- FUJIFILM Diosynth Biotechnologies
- UniQure
- Aldevron
- Richter-Helm
- Eurogentec
- OBiO Technology
- Yposkesi
- Cell and Gene Therapy Catapult
- MassBiologics
- Biovian
- VGXI
- Gene Synthesis
- PlasmidFactory
- Jikai Gene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vector and Plasmid DNA Market Size (2020-2031)
2.1.2 Viral Vector and Plasmid DNA Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Viral Vector and Plasmid DNA by Country/Region (2020, 2024 & 2031)
2.2 Viral Vector and Plasmid DNA Segment by Type
2.2.1 Plasmid DNA
2.2.2 Viral Vector
2.3 Viral Vector and Plasmid DNA Market Size by Type
2.3.1 Viral Vector and Plasmid DNA Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2020-2025)
2.4 Viral Vector and Plasmid DNA Segment by Application
2.4.1 Cancer
2.4.2 Virus Infection
2.4.3 Hereditary Disease
2.5 Viral Vector and Plasmid DNA Market Size by Application
2.5.1 Viral Vector and Plasmid DNA Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
3 VIRAL VECTOR AND PLASMID DNA MARKET SIZE BY PLAYER
3.1 Viral Vector and Plasmid DNA Market Size Market Share by Player
3.1.1 Global Viral Vector and Plasmid DNA Revenue by Player (2020-2025)
3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Player (2020-2025)
3.2 Global Viral Vector and Plasmid DNA Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR AND PLASMID DNA BY REGION
4.1 Viral Vector and Plasmid DNA Market Size by Region (2020-2025)
4.2 Global Viral Vector and Plasmid DNA Annual Revenue by Country/Region (2020-2025)
4.3 Americas Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.4 APAC Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.5 Europe Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.6 Middle East & Africa Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Viral Vector and Plasmid DNA Market Size by Country (2020-2025)
5.2 Americas Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
5.3 Americas Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector and Plasmid DNA Market Size by Region (2020-2025)
6.2 APAC Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
6.3 APAC Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Vector and Plasmid DNA Market Size by Country (2020-2025)
7.2 Europe Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vector and Plasmid DNA by Region (2020-2025)
8.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
8.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET FORECAST
10.1 Global Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.1.1 Global Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.1.2 Americas Viral Vector and Plasmid DNA Forecast
10.1.3 APAC Viral Vector and Plasmid DNA Forecast
10.1.4 Europe Viral Vector and Plasmid DNA Forecast
10.1.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast
10.2 Americas Viral Vector and Plasmid DNA Forecast by Country (2026-2031)
10.2.1 United States Market Viral Vector and Plasmid DNA Forecast
10.2.2 Canada Market Viral Vector and Plasmid DNA Forecast
10.2.3 Mexico Market Viral Vector and Plasmid DNA Forecast
10.2.4 Brazil Market Viral Vector and Plasmid DNA Forecast
10.3 APAC Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.3.1 China Viral Vector and Plasmid DNA Market Forecast
10.3.2 Japan Market Viral Vector and Plasmid DNA Forecast
10.3.3 Korea Market Viral Vector and Plasmid DNA Forecast
10.3.4 Southeast Asia Market Viral Vector and Plasmid DNA Forecast
10.3.5 India Market Viral Vector and Plasmid DNA Forecast
10.3.6 Australia Market Viral Vector and Plasmid DNA Forecast
10.4 Europe Viral Vector and Plasmid DNA Forecast by Country (2026-2031)
10.4.1 Germany Market Viral Vector and Plasmid DNA Forecast
10.4.2 France Market Viral Vector and Plasmid DNA Forecast
10.4.3 UK Market Viral Vector and Plasmid DNA Forecast
10.4.4 Italy Market Viral Vector and Plasmid DNA Forecast
10.4.5 Russia Market Viral Vector and Plasmid DNA Forecast
10.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.5.1 Egypt Market Viral Vector and Plasmid DNA Forecast
10.5.2 South Africa Market Viral Vector and Plasmid DNA Forecast
10.5.3 Israel Market Viral Vector and Plasmid DNA Forecast
10.5.4 Turkey Market Viral Vector and Plasmid DNA Forecast
10.6 Global Viral Vector and Plasmid DNA Forecast by Type (2026-2031)
10.7 Global Viral Vector and Plasmid DNA Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Viral Vector and Plasmid DNA Forecast
11 KEY PLAYERS ANALYSIS
11.1 Brammer Bio
11.1.1 Brammer Bio Company Information
11.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Offered
11.1.3 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Brammer Bio Main Business Overview
11.1.5 Brammer Bio Latest Developments
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Information
11.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Oxford BioMedica Main Business Overview
11.2.5 Oxford BioMedica Latest Developments
11.3 Cobra Biologics
11.3.1 Cobra Biologics Company Information
11.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Offered
11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Cobra Biologics Main Business Overview
11.3.5 Cobra Biologics Latest Developments
11.4 FinVector
11.4.1 FinVector Company Information
11.4.2 FinVector Viral Vector and Plasmid DNA Product Offered
11.4.3 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 FinVector Main Business Overview
11.4.5 FinVector Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Viral Vector and Plasmid DNA Product Offered
11.5.3 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 BioReliance
11.6.1 BioReliance Company Information
11.6.2 BioReliance Viral Vector and Plasmid DNA Product Offered
11.6.3 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioReliance Main Business Overview
11.6.5 BioReliance Latest Developments
11.7 MolMed
11.7.1 MolMed Company Information
11.7.2 MolMed Viral Vector and Plasmid DNA Product Offered
11.7.3 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 MolMed Main Business Overview
11.7.5 MolMed Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 UniQure
11.9.1 UniQure Company Information
11.9.2 UniQure Viral Vector and Plasmid DNA Product Offered
11.9.3 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 UniQure Main Business Overview
11.9.5 UniQure Latest Developments
11.10 Aldevron
11.10.1 Aldevron Company Information
11.10.2 Aldevron Viral Vector and Plasmid DNA Product Offered
11.10.3 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Aldevron Main Business Overview
11.10.5 Aldevron Latest Developments
11.11 Richter-Helm
11.11.1 Richter-Helm Company Information
11.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Offered
11.11.3 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Richter-Helm Main Business Overview
11.11.5 Richter-Helm Latest Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Information
11.12.2 Eurogentec Viral Vector and Plasmid DNA Product Offered
11.12.3 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eurogentec Main Business Overview
11.12.5 Eurogentec Latest Developments
11.13 OBiO Technology
11.13.1 OBiO Technology Company Information
11.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Offered
11.13.3 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 OBiO Technology Main Business Overview
11.13.5 OBiO Technology Latest Developments
11.14 Yposkesi
11.14.1 Yposkesi Company Information
11.14.2 Yposkesi Viral Vector and Plasmid DNA Product Offered
11.14.3 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Yposkesi Main Business Overview
11.14.5 Yposkesi Latest Developments
11.15 Cell and Gene Therapy Catapult
11.15.1 Cell and Gene Therapy Catapult Company Information
11.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Offered
11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Cell and Gene Therapy Catapult Main Business Overview
11.15.5 Cell and Gene Therapy Catapult Latest Developments
11.16 MassBiologics
11.16.1 MassBiologics Company Information
11.16.2 MassBiologics Viral Vector and Plasmid DNA Product Offered
11.16.3 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 MassBiologics Main Business Overview
11.16.5 MassBiologics Latest Developments
11.17 Biovian
11.17.1 Biovian Company Information
11.17.2 Biovian Viral Vector and Plasmid DNA Product Offered
11.17.3 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biovian Main Business Overview
11.17.5 Biovian Latest Developments
11.18 VGXI
11.18.1 VGXI Company Information
11.18.2 VGXI Viral Vector and Plasmid DNA Product Offered
11.18.3 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 VGXI Main Business Overview
11.18.5 VGXI Latest Developments
11.19 Gene Synthesis
11.19.1 Gene Synthesis Company Information
11.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Offered
11.19.3 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Gene Synthesis Main Business Overview
11.19.5 Gene Synthesis Latest Developments
11.20 PlasmidFactory
11.20.1 PlasmidFactory Company Information
11.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Offered
11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 PlasmidFactory Main Business Overview
11.20.5 PlasmidFactory Latest Developments
11.21 Jikai Gene
11.21.1 Jikai Gene Company Information
11.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Offered
11.21.3 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Jikai Gene Main Business Overview
11.21.5 Jikai Gene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Viral Vector and Plasmid DNA Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Viral Vector and Plasmid DNA Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmid DNA
Table 4. Major Players of Viral Vector
Table 5. Viral Vector and Plasmid DNA Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 7. Global Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Table 8. Viral Vector and Plasmid DNA Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Table 11. Global Viral Vector and Plasmid DNA Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Viral Vector and Plasmid DNA Revenue Market Share by Player (2020-2025)
Table 13. Viral Vector and Plasmid DNA Key Players Head office and Products Offered
Table 14. Viral Vector and Plasmid DNA Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Table 19. Global Viral Vector and Plasmid DNA Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Viral Vector and Plasmid DNA Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Viral Vector and Plasmid DNA Market Size Market Share by Country (2020-2025)
Table 23. Americas Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Table 25. Americas Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Table 27. APAC Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Table 29. APAC Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country (2020-2025)
Table 33. Europe Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Viral Vector and Plasmid DNA
Table 39. Key Market Challenges & Risks of Viral Vector and Plasmid DNA
Table 40. Key IndustryTrends of Viral Vector and Plasmid DNA
Table 41. Global Viral Vector and Plasmid DNA Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Viral Vector and Plasmid DNA Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Viral Vector and Plasmid DNA Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Brammer Bio Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 46. Brammer Bio Viral Vector and Plasmid DNA Product Offered
Table 47. Brammer Bio Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Brammer Bio Main Business
Table 49. Brammer Bio Latest Developments
Table 50. Oxford BioMedica Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 51. Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
Table 52. Oxford BioMedica Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Oxford BioMedica Main Business
Table 54. Oxford BioMedica Latest Developments
Table 55. Cobra Biologics Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 56. Cobra Biologics Viral Vector and Plasmid DNA Product Offered
Table 57. Cobra Biologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Cobra Biologics Main Business
Table 59. Cobra Biologics Latest Developments
Table 60.FinVector Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 61.FinVector Viral Vector and Plasmid DNA Product Offered
Table 62.FinVector Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.FinVector Main Business
Table 64.FinVector Latest Developments
Table 65. Lonza Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 66. Lonza Viral Vector and Plasmid DNA Product Offered
Table 67. Lonza Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Lonza Main Business
Table 69. Lonza Latest Developments
Table 70. BioReliance Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 71. BioReliance Viral Vector and Plasmid DNA Product Offered
Table 72. BioReliance Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioReliance Main Business
Table 74. BioReliance Latest Developments
Table 75. MolMed Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 76. MolMed Viral Vector and Plasmid DNA Product Offered
Table 77. MolMed Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. MolMed Main Business
Table 79. MolMed Latest Developments
Table 80.FUJIFILM Diosynth Biotechnologies Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 81.FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
Table 82.FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83.FUJIFILM Diosynth Biotechnologies Main Business
Table 84.FUJIFILM Diosynth Biotechnologies Latest Developments
Table 85. UniQure Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 86. UniQure Viral Vector and Plasmid DNA Product Offered
Table 87. UniQure Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. UniQure Main Business
Table 89. UniQure Latest Developments
Table 90. Aldevron Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 91. Aldevron Viral Vector and Plasmid DNA Product Offered
Table 92. Aldevron Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Aldevron Main Business
Table 94. Aldevron Latest Developments
Table 95. Richter-Helm Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 96. Richter-Helm Viral Vector and Plasmid DNA Product Offered
Table 97. Richter-Helm Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Richter-Helm Main Business
Table 99. Richter-Helm Latest Developments
Table 100. Eurogentec Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 101. Eurogentec Viral Vector and Plasmid DNA Product Offered
Table 102. Eurogentec Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Eurogentec Main Business
Table 104. Eurogentec Latest Developments
Table 105. OBiOTechnology Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 106. OBiOTechnology Viral Vector and Plasmid DNA Product Offered
Table 107. OBiOTechnology Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. OBiOTechnology Main Business
Table 109. OBiOTechnology Latest Developments
Table 110. Yposkesi Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 111. Yposkesi Viral Vector and Plasmid DNA Product Offered
Table 112. Yposkesi Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Yposkesi Main Business
Table 114. Yposkesi Latest Developments
Table 115. Cell and GeneTherapy Catapult Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 116. Cell and GeneTherapy Catapult Viral Vector and Plasmid DNA Product Offered
Table 117. Cell and GeneTherapy Catapult Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Cell and GeneTherapy Catapult Main Business
Table 119. Cell and GeneTherapy Catapult Latest Developments
Table 120. MassBiologics Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 121. MassBiologics Viral Vector and Plasmid DNA Product Offered
Table 122. MassBiologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. MassBiologics Main Business
Table 124. MassBiologics Latest Developments
Table 125. Biovian Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 126. Biovian Viral Vector and Plasmid DNA Product Offered
Table 127. Biovian Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Biovian Main Business
Table 129. Biovian Latest Developments
Table 130. VGXI Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 131. VGXI Viral Vector and Plasmid DNA Product Offered
Table 132. VGXI Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. VGXI Main Business
Table 134. VGXI Latest Developments
Table 135. Gene Synthesis Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 136. Gene Synthesis Viral Vector and Plasmid DNA Product Offered
Table 137. Gene Synthesis Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Gene Synthesis Main Business
Table 139. Gene Synthesis Latest Developments
Table 140. PlasmidFactory Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 141. PlasmidFactory Viral Vector and Plasmid DNA Product Offered
Table 142. PlasmidFactory Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. PlasmidFactory Main Business
Table 144. PlasmidFactory Latest Developments
Table 145. Jikai Gene Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 146. Jikai Gene Viral Vector and Plasmid DNA Product Offered
Table 147. Jikai Gene Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Jikai Gene Main Business
Table 149. Jikai Gene Latest Developments
LIST OFFIGURES
Figure 1. Viral Vector and Plasmid DNA Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector and Plasmid DNA Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Viral Vector and Plasmid DNA Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Viral Vector and Plasmid DNA Sales Market Share by Country/Region (2024)
Figure 8. Viral Vector and Plasmid DNA Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Viral Vector and Plasmid DNA Market Size Market Share byType in 2024
Figure 10. Viral Vector and Plasmid DNA in Cancer
Figure 11. Global Viral Vector and Plasmid DNA Market: Cancer (2020-2025) & ($ millions)
Figure 12. Viral Vector and Plasmid DNA in Virus Infection
Figure 13. Global Viral Vector and Plasmid DNA Market: Virus Infection (2020-2025) & ($ millions)
Figure 14. Viral Vector and Plasmid DNA in Hereditary Disease
Figure 15. Global Viral Vector and Plasmid DNA Market: Hereditary Disease (2020-2025) & ($ millions)
Figure 16. Global Viral Vector and Plasmid DNA Market Size Market Share by Application in 2024
Figure 17. Global Viral Vector and Plasmid DNA Revenue Market Share by Player in 2024
Figure 18. Global Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Figure 19. Americas Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 20. APAC Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 21. Europe Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 23. Americas Viral Vector and Plasmid DNA Value Market Share by Country in 2024
Figure 24. United States Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Viral Vector and Plasmid DNA Market Size Market Share by Region in 2024
Figure 29. APAC Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 30. APAC Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 31. China Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 35. India Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country in 2024
Figure 38. Europe Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 39. Europe Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 40. Germany Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 41.France Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 54. APAC Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 55. Europe Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 57. United States Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 58. Canada Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 59. Mexico Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 60. Brazil Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 61. China Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 62. Japan Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 63. Korea Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 65. India Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 66. Australia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 67. Germany Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 68.France Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 69. UK Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 70. Italy Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 71. Russia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 72. Egypt Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 73. South Africa Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 74. Israel Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 75.Turkey Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 76. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vector and Plasmid DNA Market Size (2020-2031)
2.1.2 Viral Vector and Plasmid DNA Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Viral Vector and Plasmid DNA by Country/Region (2020, 2024 & 2031)
2.2 Viral Vector and Plasmid DNA Segment by Type
2.2.1 Plasmid DNA
2.2.2 Viral Vector
2.3 Viral Vector and Plasmid DNA Market Size by Type
2.3.1 Viral Vector and Plasmid DNA Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2020-2025)
2.4 Viral Vector and Plasmid DNA Segment by Application
2.4.1 Cancer
2.4.2 Virus Infection
2.4.3 Hereditary Disease
2.5 Viral Vector and Plasmid DNA Market Size by Application
2.5.1 Viral Vector and Plasmid DNA Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
3 VIRAL VECTOR AND PLASMID DNA MARKET SIZE BY PLAYER
3.1 Viral Vector and Plasmid DNA Market Size Market Share by Player
3.1.1 Global Viral Vector and Plasmid DNA Revenue by Player (2020-2025)
3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Player (2020-2025)
3.2 Global Viral Vector and Plasmid DNA Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR AND PLASMID DNA BY REGION
4.1 Viral Vector and Plasmid DNA Market Size by Region (2020-2025)
4.2 Global Viral Vector and Plasmid DNA Annual Revenue by Country/Region (2020-2025)
4.3 Americas Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.4 APAC Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.5 Europe Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
4.6 Middle East & Africa Viral Vector and Plasmid DNA Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Viral Vector and Plasmid DNA Market Size by Country (2020-2025)
5.2 Americas Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
5.3 Americas Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector and Plasmid DNA Market Size by Region (2020-2025)
6.2 APAC Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
6.3 APAC Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Vector and Plasmid DNA Market Size by Country (2020-2025)
7.2 Europe Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vector and Plasmid DNA by Region (2020-2025)
8.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2020-2025)
8.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET FORECAST
10.1 Global Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.1.1 Global Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.1.2 Americas Viral Vector and Plasmid DNA Forecast
10.1.3 APAC Viral Vector and Plasmid DNA Forecast
10.1.4 Europe Viral Vector and Plasmid DNA Forecast
10.1.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast
10.2 Americas Viral Vector and Plasmid DNA Forecast by Country (2026-2031)
10.2.1 United States Market Viral Vector and Plasmid DNA Forecast
10.2.2 Canada Market Viral Vector and Plasmid DNA Forecast
10.2.3 Mexico Market Viral Vector and Plasmid DNA Forecast
10.2.4 Brazil Market Viral Vector and Plasmid DNA Forecast
10.3 APAC Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.3.1 China Viral Vector and Plasmid DNA Market Forecast
10.3.2 Japan Market Viral Vector and Plasmid DNA Forecast
10.3.3 Korea Market Viral Vector and Plasmid DNA Forecast
10.3.4 Southeast Asia Market Viral Vector and Plasmid DNA Forecast
10.3.5 India Market Viral Vector and Plasmid DNA Forecast
10.3.6 Australia Market Viral Vector and Plasmid DNA Forecast
10.4 Europe Viral Vector and Plasmid DNA Forecast by Country (2026-2031)
10.4.1 Germany Market Viral Vector and Plasmid DNA Forecast
10.4.2 France Market Viral Vector and Plasmid DNA Forecast
10.4.3 UK Market Viral Vector and Plasmid DNA Forecast
10.4.4 Italy Market Viral Vector and Plasmid DNA Forecast
10.4.5 Russia Market Viral Vector and Plasmid DNA Forecast
10.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast by Region (2026-2031)
10.5.1 Egypt Market Viral Vector and Plasmid DNA Forecast
10.5.2 South Africa Market Viral Vector and Plasmid DNA Forecast
10.5.3 Israel Market Viral Vector and Plasmid DNA Forecast
10.5.4 Turkey Market Viral Vector and Plasmid DNA Forecast
10.6 Global Viral Vector and Plasmid DNA Forecast by Type (2026-2031)
10.7 Global Viral Vector and Plasmid DNA Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Viral Vector and Plasmid DNA Forecast
11 KEY PLAYERS ANALYSIS
11.1 Brammer Bio
11.1.1 Brammer Bio Company Information
11.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Offered
11.1.3 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Brammer Bio Main Business Overview
11.1.5 Brammer Bio Latest Developments
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Information
11.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Oxford BioMedica Main Business Overview
11.2.5 Oxford BioMedica Latest Developments
11.3 Cobra Biologics
11.3.1 Cobra Biologics Company Information
11.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Offered
11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Cobra Biologics Main Business Overview
11.3.5 Cobra Biologics Latest Developments
11.4 FinVector
11.4.1 FinVector Company Information
11.4.2 FinVector Viral Vector and Plasmid DNA Product Offered
11.4.3 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 FinVector Main Business Overview
11.4.5 FinVector Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Viral Vector and Plasmid DNA Product Offered
11.5.3 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 BioReliance
11.6.1 BioReliance Company Information
11.6.2 BioReliance Viral Vector and Plasmid DNA Product Offered
11.6.3 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioReliance Main Business Overview
11.6.5 BioReliance Latest Developments
11.7 MolMed
11.7.1 MolMed Company Information
11.7.2 MolMed Viral Vector and Plasmid DNA Product Offered
11.7.3 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 MolMed Main Business Overview
11.7.5 MolMed Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 UniQure
11.9.1 UniQure Company Information
11.9.2 UniQure Viral Vector and Plasmid DNA Product Offered
11.9.3 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 UniQure Main Business Overview
11.9.5 UniQure Latest Developments
11.10 Aldevron
11.10.1 Aldevron Company Information
11.10.2 Aldevron Viral Vector and Plasmid DNA Product Offered
11.10.3 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Aldevron Main Business Overview
11.10.5 Aldevron Latest Developments
11.11 Richter-Helm
11.11.1 Richter-Helm Company Information
11.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Offered
11.11.3 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Richter-Helm Main Business Overview
11.11.5 Richter-Helm Latest Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Information
11.12.2 Eurogentec Viral Vector and Plasmid DNA Product Offered
11.12.3 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eurogentec Main Business Overview
11.12.5 Eurogentec Latest Developments
11.13 OBiO Technology
11.13.1 OBiO Technology Company Information
11.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Offered
11.13.3 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 OBiO Technology Main Business Overview
11.13.5 OBiO Technology Latest Developments
11.14 Yposkesi
11.14.1 Yposkesi Company Information
11.14.2 Yposkesi Viral Vector and Plasmid DNA Product Offered
11.14.3 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Yposkesi Main Business Overview
11.14.5 Yposkesi Latest Developments
11.15 Cell and Gene Therapy Catapult
11.15.1 Cell and Gene Therapy Catapult Company Information
11.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Offered
11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Cell and Gene Therapy Catapult Main Business Overview
11.15.5 Cell and Gene Therapy Catapult Latest Developments
11.16 MassBiologics
11.16.1 MassBiologics Company Information
11.16.2 MassBiologics Viral Vector and Plasmid DNA Product Offered
11.16.3 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 MassBiologics Main Business Overview
11.16.5 MassBiologics Latest Developments
11.17 Biovian
11.17.1 Biovian Company Information
11.17.2 Biovian Viral Vector and Plasmid DNA Product Offered
11.17.3 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biovian Main Business Overview
11.17.5 Biovian Latest Developments
11.18 VGXI
11.18.1 VGXI Company Information
11.18.2 VGXI Viral Vector and Plasmid DNA Product Offered
11.18.3 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 VGXI Main Business Overview
11.18.5 VGXI Latest Developments
11.19 Gene Synthesis
11.19.1 Gene Synthesis Company Information
11.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Offered
11.19.3 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Gene Synthesis Main Business Overview
11.19.5 Gene Synthesis Latest Developments
11.20 PlasmidFactory
11.20.1 PlasmidFactory Company Information
11.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Offered
11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 PlasmidFactory Main Business Overview
11.20.5 PlasmidFactory Latest Developments
11.21 Jikai Gene
11.21.1 Jikai Gene Company Information
11.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Offered
11.21.3 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Jikai Gene Main Business Overview
11.21.5 Jikai Gene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Viral Vector and Plasmid DNA Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Viral Vector and Plasmid DNA Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmid DNA
Table 4. Major Players of Viral Vector
Table 5. Viral Vector and Plasmid DNA Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 7. Global Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Table 8. Viral Vector and Plasmid DNA Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Table 11. Global Viral Vector and Plasmid DNA Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Viral Vector and Plasmid DNA Revenue Market Share by Player (2020-2025)
Table 13. Viral Vector and Plasmid DNA Key Players Head office and Products Offered
Table 14. Viral Vector and Plasmid DNA Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Table 19. Global Viral Vector and Plasmid DNA Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Viral Vector and Plasmid DNA Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Viral Vector and Plasmid DNA Market Size Market Share by Country (2020-2025)
Table 23. Americas Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Table 25. Americas Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Table 27. APAC Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Table 29. APAC Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Viral Vector and Plasmid DNA Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country (2020-2025)
Table 33. Europe Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Viral Vector and Plasmid DNA Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Viral Vector and Plasmid DNA
Table 39. Key Market Challenges & Risks of Viral Vector and Plasmid DNA
Table 40. Key IndustryTrends of Viral Vector and Plasmid DNA
Table 41. Global Viral Vector and Plasmid DNA Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Viral Vector and Plasmid DNA Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Viral Vector and Plasmid DNA Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Brammer Bio Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 46. Brammer Bio Viral Vector and Plasmid DNA Product Offered
Table 47. Brammer Bio Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Brammer Bio Main Business
Table 49. Brammer Bio Latest Developments
Table 50. Oxford BioMedica Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 51. Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
Table 52. Oxford BioMedica Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Oxford BioMedica Main Business
Table 54. Oxford BioMedica Latest Developments
Table 55. Cobra Biologics Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 56. Cobra Biologics Viral Vector and Plasmid DNA Product Offered
Table 57. Cobra Biologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Cobra Biologics Main Business
Table 59. Cobra Biologics Latest Developments
Table 60.FinVector Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 61.FinVector Viral Vector and Plasmid DNA Product Offered
Table 62.FinVector Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.FinVector Main Business
Table 64.FinVector Latest Developments
Table 65. Lonza Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 66. Lonza Viral Vector and Plasmid DNA Product Offered
Table 67. Lonza Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Lonza Main Business
Table 69. Lonza Latest Developments
Table 70. BioReliance Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 71. BioReliance Viral Vector and Plasmid DNA Product Offered
Table 72. BioReliance Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioReliance Main Business
Table 74. BioReliance Latest Developments
Table 75. MolMed Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 76. MolMed Viral Vector and Plasmid DNA Product Offered
Table 77. MolMed Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. MolMed Main Business
Table 79. MolMed Latest Developments
Table 80.FUJIFILM Diosynth Biotechnologies Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 81.FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
Table 82.FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83.FUJIFILM Diosynth Biotechnologies Main Business
Table 84.FUJIFILM Diosynth Biotechnologies Latest Developments
Table 85. UniQure Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 86. UniQure Viral Vector and Plasmid DNA Product Offered
Table 87. UniQure Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. UniQure Main Business
Table 89. UniQure Latest Developments
Table 90. Aldevron Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 91. Aldevron Viral Vector and Plasmid DNA Product Offered
Table 92. Aldevron Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Aldevron Main Business
Table 94. Aldevron Latest Developments
Table 95. Richter-Helm Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 96. Richter-Helm Viral Vector and Plasmid DNA Product Offered
Table 97. Richter-Helm Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Richter-Helm Main Business
Table 99. Richter-Helm Latest Developments
Table 100. Eurogentec Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 101. Eurogentec Viral Vector and Plasmid DNA Product Offered
Table 102. Eurogentec Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Eurogentec Main Business
Table 104. Eurogentec Latest Developments
Table 105. OBiOTechnology Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 106. OBiOTechnology Viral Vector and Plasmid DNA Product Offered
Table 107. OBiOTechnology Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. OBiOTechnology Main Business
Table 109. OBiOTechnology Latest Developments
Table 110. Yposkesi Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 111. Yposkesi Viral Vector and Plasmid DNA Product Offered
Table 112. Yposkesi Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Yposkesi Main Business
Table 114. Yposkesi Latest Developments
Table 115. Cell and GeneTherapy Catapult Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 116. Cell and GeneTherapy Catapult Viral Vector and Plasmid DNA Product Offered
Table 117. Cell and GeneTherapy Catapult Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Cell and GeneTherapy Catapult Main Business
Table 119. Cell and GeneTherapy Catapult Latest Developments
Table 120. MassBiologics Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 121. MassBiologics Viral Vector and Plasmid DNA Product Offered
Table 122. MassBiologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. MassBiologics Main Business
Table 124. MassBiologics Latest Developments
Table 125. Biovian Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 126. Biovian Viral Vector and Plasmid DNA Product Offered
Table 127. Biovian Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Biovian Main Business
Table 129. Biovian Latest Developments
Table 130. VGXI Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 131. VGXI Viral Vector and Plasmid DNA Product Offered
Table 132. VGXI Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. VGXI Main Business
Table 134. VGXI Latest Developments
Table 135. Gene Synthesis Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 136. Gene Synthesis Viral Vector and Plasmid DNA Product Offered
Table 137. Gene Synthesis Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Gene Synthesis Main Business
Table 139. Gene Synthesis Latest Developments
Table 140. PlasmidFactory Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 141. PlasmidFactory Viral Vector and Plasmid DNA Product Offered
Table 142. PlasmidFactory Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. PlasmidFactory Main Business
Table 144. PlasmidFactory Latest Developments
Table 145. Jikai Gene Details, CompanyType, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 146. Jikai Gene Viral Vector and Plasmid DNA Product Offered
Table 147. Jikai Gene Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Jikai Gene Main Business
Table 149. Jikai Gene Latest Developments
LIST OFFIGURES
Figure 1. Viral Vector and Plasmid DNA Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector and Plasmid DNA Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Viral Vector and Plasmid DNA Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Viral Vector and Plasmid DNA Sales Market Share by Country/Region (2024)
Figure 8. Viral Vector and Plasmid DNA Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Viral Vector and Plasmid DNA Market Size Market Share byType in 2024
Figure 10. Viral Vector and Plasmid DNA in Cancer
Figure 11. Global Viral Vector and Plasmid DNA Market: Cancer (2020-2025) & ($ millions)
Figure 12. Viral Vector and Plasmid DNA in Virus Infection
Figure 13. Global Viral Vector and Plasmid DNA Market: Virus Infection (2020-2025) & ($ millions)
Figure 14. Viral Vector and Plasmid DNA in Hereditary Disease
Figure 15. Global Viral Vector and Plasmid DNA Market: Hereditary Disease (2020-2025) & ($ millions)
Figure 16. Global Viral Vector and Plasmid DNA Market Size Market Share by Application in 2024
Figure 17. Global Viral Vector and Plasmid DNA Revenue Market Share by Player in 2024
Figure 18. Global Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Figure 19. Americas Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 20. APAC Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 21. Europe Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2020-2025 ($ millions)
Figure 23. Americas Viral Vector and Plasmid DNA Value Market Share by Country in 2024
Figure 24. United States Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Viral Vector and Plasmid DNA Market Size Market Share by Region in 2024
Figure 29. APAC Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 30. APAC Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 31. China Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 35. India Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country in 2024
Figure 38. Europe Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 39. Europe Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 40. Germany Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 41.France Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Viral Vector and Plasmid DNA Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 54. APAC Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 55. Europe Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 57. United States Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 58. Canada Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 59. Mexico Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 60. Brazil Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 61. China Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 62. Japan Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 63. Korea Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 65. India Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 66. Australia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 67. Germany Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 68.France Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 69. UK Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 70. Italy Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 71. Russia Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 72. Egypt Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 73. South Africa Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 74. Israel Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 75.Turkey Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
Figure 76. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Viral Vector and Plasmid DNA Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Viral Vector and Plasmid DNA Market Size 2026-2031 ($ millions)
More Publications
Global Pharma Clinical Trial Services Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
87 pages
Global Shockwave Therapy System Market Growth 2024-2030
US$ 3,660.00
December 2024
114 pages
Global Non-invasive Cerebral Oxygen Monitor Market Growth 2025-2031
US$ 3,660.00
June 2025
109 pages
Global Vacuum Therapy Units Market Growth 2024-2030
US$ 3,660.00
March 2024
92 pages
Global UV Germicidal Lamp Market Growth 2025-2031
US$ 3,660.00
January 2025
86 pages
